|
|
||||||||
Ann Thorac Surg 2007;84:690-692
© 2007 The Society of Thoracic Surgeons
Cardiothoracic Surgery, Thoraxcentrum Twente, Enschede, the Netherlands
Accepted for publication December 11, 2006.
* Address correspondence to Dr Mariani, Thoraxcentrum Twente, Haaksbergerstraat 55, PO Box 50 000, Enschede, 7500 KA, the Netherlands (Email: m.mariani{at}ziekenhuis-mst.nl).
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
The PulseCath is a disposable heart assist device with a counterpulsation effect. With a pump flow of 2 to 3 L per minute. The pulsatile pumping action is similar to the intra-aortic balloon pump (IABP), with aspiration during systole and ejection during diastole, close to the inflow openings of the coronary arteries. The main difference is that the PulseCath directly unloads the heart by active aspiration from the left ventricle, thus decreasing the oxygen demand. The PulseCath has been previously tested only in animal models as a temporary assist device [3, 4]. We report a clinical study using the Pulse-Cath for patients with left ventricular dysfunction undergoing off-pump coronary artery surgery.
From January 2005 to March 2006, 14 patients undergoing coronary artery bypass grafting surgery were supported by the PulseCath during off-pump coronary artery surgery. Patients with a predicted mortality of 6% or more according to the logarithmic EuroSCORE (European System for Cardiac Operative Risk Evaluation) and left ventricular dysfunction (below 40%) were included. The exclusion criteria were aortic wall disease, valve disease, previous cardiac surgery, and left ventricular thrombus. The 14 patients, 13 male and 1 female, had a mean age of 68.8 ± 7.0 years, mean length of 173 cm ± 10 cm, and mean weight of 79.9 kg ± 13.7 kg. The mean preoperative left ventricular ejection fraction was 28% ± 8%. The mean predicted mortality was 8.9% (EuroSCORE).
The PulseCath consists of a thin-walled catheter with a diameter of 21F, connected to a single port membrane pump [3–7]. The position of the PulseCath in the heart is schematically outlined in Figure 1. The tip of the catheter is positioned in the left ventricular cavity, the two-way valve is positioned in the aorta, and the membrane pump is located outside the body. The patented two-way valve is designed to guide the blood in the correct direction. The valve consists of a tubular housing and one moving part (leaflet) that pivots around an axis. The membrane pump has a blood chamber and an air chamber, divided by a flexible membrane. The membrane pump is activated by a standard IABP driver. During pump aspiration, the blood flows from the left ventricle to the membrane pump, and during pump ejection, the PulseCath valve guides the blood into the aorta, preventing backflow in the left ventricle.
|
| Technique |
|---|
|
|
|---|
After exposure of the heart, a double pursestring suture was placed on the aorta, approximately 6 cm above the aortic valve. A guidewire was inserted in the aorta toward the aortic valve. An angled pigtail catheter was inserted over the guidewire, through the aortic valve, into the left ventricle. The PulseCath was then guided over the pigtail catheter, until the distal tip was in the left ventricle. The correct position of the catheter (tip in the ventricle and valve in the aorta) was determined using transesophageal echocardiography. After correct position was verified, the insertion set was removed, and a tube clamp was placed on the connector part on the proximal side of the catheter.
In the mean time, the membrane pump was filled with heparinized saline. The membrane pump was then connected to the connector of the catheter, using standard tubing methods. The catheter was fixed to the aortic wall with the pursestring sutures. One side of the drive line extension was connected to the air line of the membrane pump, the opposite end to a CS100 IABP driver (Datascope, New York, NY).
Electrocardiographic triggering and semiautomatic mode were applied in all patients. The timing of the IABP driver was the same as for the IABP. Correct timing was determined by observing the shape of the arterial pressure curvature. Inflation was set as soon as the slope of the arterial pressure curve was decreasing, deflation was set before the systole of the heart.
The flow generated by the PulseCath was measured using a Transonic HT110 flowmeter (Transonic Systems, Ithaca, New York). The sensor was placed around the connector at the proximal side of the catheter. Because the aspired and ejected blood flows through the same catheter, the determined average flow is zero. Therefore, the measured flow pattern was recalculated by a computer program, using the "pattern" output of the flowmeter.
After the anastomoses were completed, the IABP driver was switched off. The catheter was pulled backward, and the pursestring sutures were closed.
| Comment |
|---|
|
|
|---|
|
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
K. Anastasiadis, O. Chalvatzoulis, P. Antonitsis, P. Tossios, and C. Papakonstantinou Left Ventricular Decompression During Peripheral Extracorporeal Membrane Oxygenation Support With the Use of the Novel iVAC Pulsatile Paracorporeal Assist Device Ann. Thorac. Surg., December 1, 2011; 92(6): 2257 - 2259. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Arrigoni, M. Kuijpers, G. Mecozzi, and M. A. Mariani PulseCath(R) as a right ventricular assist device Interact CardioVasc Thorac Surg, June 1, 2011; 12(6): 891 - 894. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Niclauss and L. K. Segesser PulseCath iVAC 3LTM hemodynamic performance for simple assisted flow Interact CardioVasc Thorac Surg, June 1, 2011; 12(6): 912 - 913. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |